# Kinnate Biopharma (stock symbol: KNTE) Logo in transparent PNG and SVG formats

## Kinnate Biopharma Logo large

### Kinnate Biopharma Logo large Download PNG (28.57 KB)

![Kinnate Biopharma Logo large Download PNG (28.57 KB)](/img/orig/KNTE_BIG-50d165e3.png)

### Kinnate Biopharma Logo large Download SVG (5.23 KB)

![Kinnate Biopharma Logo large Download SVG (5.23 KB)](/img/orig/KNTE_BIG-57944772.svg)

## Kinnate Biopharma Logo icon format

### Kinnate Biopharma Logo icon format Download PNG (53.28 KB)

![Kinnate Biopharma Logo icon format Download PNG (53.28 KB)](/img/orig/KNTE-f1358027.png)

### Kinnate Biopharma Logo icon format Download SVG (1.34 KB)

![Kinnate Biopharma Logo icon format Download SVG (1.34 KB)](/img/orig/KNTE-52c5f63d.svg)

## Kinnate Biopharma Logo large for dark backgrounds

### Kinnate Biopharma Logo large for dark backgrounds Download PNG (28.03 KB)

![Kinnate Biopharma Logo large for dark backgrounds Download PNG (28.03 KB)](/img/orig/KNTE_BIG.D-16f7d444.png)

### Kinnate Biopharma Logo large for dark backgrounds Download SVG (5.23 KB)

![Kinnate Biopharma Logo large for dark backgrounds Download SVG (5.23 KB)](/img/orig/KNTE_BIG.D-aaa2b8f0.svg)

## Kinnate Biopharma Logo icon format for dark backgrounds

### Kinnate Biopharma Logo icon format for dark backgrounds Download PNG (51.95 KB)

![Kinnate Biopharma Logo icon format for dark backgrounds Download PNG (51.95 KB)](/img/orig/KNTE.D-c6a4b378.png)

### Kinnate Biopharma Logo icon format for dark backgrounds Download SVG (1.34 KB)

![Kinnate Biopharma Logo icon format for dark backgrounds Download SVG (1.34 KB)](/img/orig/KNTE.D-78c6584f.svg)

## About Kinnate Biopharma

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.

1. Website domain: kinnate.com
2. Employees: 82
3. Marketcap: $0.11 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
